Magovcevic-Liebisch Ivana has filed 26 insider transactions across 4 companies since June 2023.
Most recent transaction: a grant/award of 23372 shares of Quanterix Corp ($QTRX) on January 02, 2026.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Quanterix Corp | $QTRX | Magovcevic-Liebisch Ivana | Not found | A | Common Stock | 23372 | $0.00 | 43,607.0000 | 46,710,797 | 115.50% | 0.05% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | D | Stock Option Award (Right to Buy) | 463000 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.97% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | D | Common Stock | 222687 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.47% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | D | Stock Option Award (Right to Buy) | 369351 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.77% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | D | Stock Option Award (Right to Buy) | 210629 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.44% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | D | Stock Option Award (Right to Buy) | 405494 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.85% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | D | Stock Option Award (Right to Buy) | 43271 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.09% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | D | Stock Option Award (Right to Buy) | 282000 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.59% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | D | Stock Option Award (Right to Buy) | 370000 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.78% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | D | Stock Option Award (Right to Buy) | 485000 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 1.02% |
| June 13, 2025 | Acrivon Therapeutics, Inc. | $ACRV | Magovcevic-Liebisch Ivana | Not found | A | Stock Option (Right to Buy) | 20275 | $0.00 | 20,275.0000 | 33,791,817 | 9999.99% | 0.06% |
| March 3, 2025 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | A | Stock Option Award (Right to Buy) | 485000 | $0.00 | 485,000.0000 | 46,671,534 | 9999.99% | 1.04% |
| Jan. 2, 2025 | Quanterix Corp | $QTRX | Magovcevic-Liebisch Ivana | Not found | A | Common Stock | 7435 | $0.00 | 20,235.0000 | 0 | 58.09% | 0.00% |
| Jan. 2, 2025 | Quanterix Corp | $QTRX | Magovcevic-Liebisch Ivana | Not found | A | Stock Option (Right to Buy) | 15821 | $0.00 | 15,821.0000 | 0 | 9999.99% | 0.00% |
| Dec. 19, 2024 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | P | Common Stock | 5000 | $1.68 | 222,687.0000 | 0 | 2.30% | 0.00% |
| Dec. 18, 2024 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | P | Common Stock | 5000 | $1.67 | 217,687.0000 | 0 | 2.35% | 0.00% |
| Dec. 5, 2024 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | P | Common Stock | 5000 | $2.34 | 212,687.0000 | 0 | 2.41% | 0.00% |
| Oct. 2, 2024 | Quanterix Corp | $QTRX | Magovcevic-Liebisch Ivana | Not found | A | Common Stock | 12800 | $0.00 | 12,800.0000 | 0 | 9999.99% | 0.00% |
| Oct. 2, 2024 | Quanterix Corp | $QTRX | Magovcevic-Liebisch Ivana | Not found | A | Common Stock | 27689 | $0.00 | 27,689.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | D | Stock Option Award (Right to Buy) | 370000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | D | Stock Option Award (Right to Buy) | 282000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | A | Stock Option Award (Right to Buy) | 282000 | $0.00 | 282,000.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | A | Stock Option Award (Right to Buy) | 370000 | $0.00 | 370,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Vigil Neuroscience, Inc. | $VIGL | Magovcevic-Liebisch Ivana | President and CEO | A | Stock Option Grant (Right to Buy) | 463000 | $0.00 | 463,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Acrivon Therapeutics, Inc. | $ACRV | Magovcevic-Liebisch Ivana | Not found | A | Stock Option (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 22,078,190 | 9999.99% | 0.15% |
| June 22, 2023 | Spyre Therapeutics, Inc. | $SYRE | Magovcevic-Liebisch Ivana | Director | A | Stock Option (right to buy) | 1950000 | $0.00 | 1,950,000.0000 | 0 | 9999.99% | 0.00% |